• ChemoCentryx Secures $100M Credit to Support Avacopan’s Approval Applications, Potential Commercial Launch
  • Elevated Microparticle Levels in AAV Patients Mark Higher Risk of Blood Clots, Study Suggests
  • S. aureus Bacterium in Nose Not Linked with AAV Relapses, Study Suggests
  • ‘Favorable Outcomes’ with Treatment Likely for Older Adults with AAV, Study Finds
  • Rituxan Superior to Azathioprine in Preventing AAV Relapse, Phase 3 Trial Suggests
  • Mitochondrial DNA May Serve as Urinary Biomarker of Kidney Damage, Chinese Study Suggests
  • Nutritional Status Score Can Help Predict Prognosis of AAV Patients, Study Says
  • HHS Secretary Alex Azar Touts White House Efforts to Cure Rare Diseases
  • Inflammation Seems to Play Role in Bad Cholesterol Levels, Research Suggests
  • Disease Activity and Quality of Life Influence Work Productivity of AAV Patients, Study Finds
  • Avacopan Shows Superiority Over Steroids to Treat AAV in Phase 3 ADVOCATE Trial
  • Smoking Raises Person’s Risk of AAV, Large US Study Suggests